Ethical, Legal and Societal Implications in Pharmacogenomics
WP8 of the U-PGx project provides an Ethical, Legal and Societal Implications (ELSI) expertise and education on ethical and legal aspects regarding Pharmacogenomics (PGx). Continue reading
News
To genotype or not to genotype – that’s the question. DPWG provides recommendations for pre-emptive genotyping
In the PREPARE study participants are genotyped pre-emptively, but what to do for all other patients? Can you initiate therapy without pre-emptive testing or is genotyping necessary for specific drugs? Continue reading
6th U-PGx Personalised Medicine Day, Athens, Greece
The 6th U-PGx Personalized Medicine Day will be organized in Athens, Greece on December 13th, 2019. Continue reading
1,000 patients have been enrolled since cross-over!
As per October 1st 2018, the PREPARE study sites have crossed-over to the opposite arm! Since then, more than 1,000 patients have been enrolled in the PREPARE study. When adding this number up to the number of patients enrolled before cross-over we come to a total of 4,772 patients. Continue reading
U-PGx researcher Cathelijne van der Wouden wins PGRN Trainee Abstract award
During the Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Washington D.C. on March 13th 2019, the Pharmacogenomics Research Network (PGRN) presented a Trainee Abstract Award to U-PGx’s Cathelijne van der Wouden. Continue reading
Clinical Pharmacogenetics Implementation Consortium (CPIC) Meeting June 6-7, 2019
The Clinical Pharmacogenetics Implementation Consortium (CPIC®) Meeting will be held in Memphis, TN at St. Jude Children’s Research Hospital on June 6th (full day) and June 7th (1/2 day). CPE and CME will be offered. Information, including registration and hotel information, is available here. Continue reading
6th U-PGx Personalized Medicine Day, Stuttgart, Germany
The 6th U-PGx Personalized Medicine Day will be held in Stuttgart, Germany on the 25th of February 2019.
The 5th U-PGx Personalized Medicine Day, Liverpool UK
The 5th U-PGx Personalized Medicine Day was successfully co-organized by the Golden Helix Foundation and the University of Liverpool, both partners of the Ubiquitous Pharmacogenomics (U-PGx) project, funded by the European Commission (H2020-668353). Continue reading
Happy cross-over day!
On October 1st 2018, the PREPARE study sites have crossed-over to the opposite arm! Sites in Spain, Greece and Slovenia have been enrolling patients for the pharmacogenomics guided prescribing arm Continue reading
Dutch pharmacogenomics guidelines endorsed in Europe
Six European heathcare organisations, including the European Association of Clinical Pharmacology & Therapeutics (EACPT) and the European Association of Hospital Pharmacists (EAHP), now have endorsed the pharmacogenomic guidelines used in U-PGx. Continue reading